Anaptysbio (ANAB) Times Interest Earned (2016 - 2026)
Anaptysbio (ANAB) posted Times Interest Earned of -$1.66 for Q1 2026, down 294.1% on a QoQ basis from $0.86 in Q4 2025, and down 9.27% year-over-year from -$1.83 in Q1 2025.
Anaptysbio (ANAB) Times Interest Earned (2016 - 2026) Analysis & Trends
Anaptysbio's Times Interest Earned history runs 11 years deep, the most recent figure standing at -$1.66 for Q1 2026.
- Quarterly Times Interest Earned fell 9.27% year-over-year to -$1.66 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.26 (up 114.79% YoY) and the FY2025 annual result came in at $0.27, up 143.23% from the prior year.
- Times Interest Earned was -$1.66 for Q1 2026 at Anaptysbio, down from $0.86 in the prior quarter.
- Across five years, Times Interest Earned topped out at $23.63 in Q4 2023 and bottomed at -$44.47 in Q4 2022.
- A 5-year average of -$2.76 and a median of -$1.52 in 2025 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned tumbled 5411.97% — and 2025, when it jumped 456.94%.
- Anaptysbio's Times Interest Earned stood at -$44.47 in 2022, then soared by 153.14% to $23.63 in 2023, then plunged by 101.02% to -$0.24 in 2024, then soared by 456.94% to $0.86 in 2025, then tumbled by 294.1% to -$1.66 in 2026.
- Business Quant data shows ANAB's Times Interest Earned at -$1.66 in Q1 2026, $0.86 in Q4 2025, and $0.51 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Anaptysbio | 1.55 Bn | 1.27 Bn | - | -1.66 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.66 |
| Dec 31, 2025 | 0.86 |
| Sep 30, 2025 | 0.51 |
| Jun 30, 2025 | -1.33 |
| Mar 31, 2025 | -1.52 |
| Dec 31, 2024 | -0.24 |
| Sep 30, 2024 | -0.38 |
| Jun 30, 2024 | -2.06 |
| Mar 31, 2024 | -2.09 |
| Dec 31, 2023 | 23.63 |
| Sep 30, 2023 | -1.76 |
| Jun 30, 2023 | -9.06 |
| Mar 31, 2023 | -1.96 |
| Dec 31, 2022 | -44.47 |
| Sep 30, 2022 | -2.89 |
| Jun 30, 2022 | -1.14 |
| Mar 31, 2022 | -1.27 |
| Dec 31, 2021 | -164.85 |
| Sep 30, 2021 | -0.25 |
| Jun 30, 2021 | -0.02 |